384 related articles for article (PubMed ID: 15989996)
1. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy.
de Crevoisier R; Tucker SL; Dong L; Mohan R; Cheung R; Cox JD; Kuban DA
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):965-73. PubMed ID: 15989996
[TBL] [Abstract][Full Text] [Related]
2. Degree of Rectal Distension Seen on Prostate Radiotherapy Planning CT Scan Is Not a Negative Prognostic Factor in the Modern Era of Image-Guided Radiotherapy.
Silverman R; Johnson K; Perry C; Sundar S
Oncology; 2016; 90(1):51-6. PubMed ID: 26540171
[TBL] [Abstract][Full Text] [Related]
3. Adaptive image-guided radiotherapy (IGRT) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence.
Park SS; Yan D; McGrath S; Dilworth JT; Liang J; Ye H; Krauss DJ; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):947-52. PubMed ID: 22208964
[TBL] [Abstract][Full Text] [Related]
4. Commentary on increased risk of biochemical and local failure in patients with a distended rectum on the planning CT for prostate cancer radiotherapy.
Roach M
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):949-50. PubMed ID: 15989992
[No Abstract] [Full Text] [Related]
5. Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers.
Engels B; Soete G; Verellen D; Storme G
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):388-91. PubMed ID: 19056185
[TBL] [Abstract][Full Text] [Related]
6. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
[TBL] [Abstract][Full Text] [Related]
8. Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer.
Kupelian PA; Willoughby TR; Reddy CA; Klein EA; Mahadevan A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1146-50. PubMed ID: 17919834
[TBL] [Abstract][Full Text] [Related]
9. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
[TBL] [Abstract][Full Text] [Related]
10. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
Cozzarini C; Fiorino C; Ceresoli GL; Cattaneo GM; Bolognesi A; Calandrino R; Villa E
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):688-94. PubMed ID: 12573756
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
12. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
[TBL] [Abstract][Full Text] [Related]
13. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
[TBL] [Abstract][Full Text] [Related]
14. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
16. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.
Huang EH; Pollack A; Levy L; Starkschall G; Dong L; Rosen I; Kuban DA
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1314-21. PubMed ID: 12459352
[TBL] [Abstract][Full Text] [Related]
17. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
[TBL] [Abstract][Full Text] [Related]
18. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.
Skwarchuk MW; Jackson A; Zelefsky MJ; Venkatraman ES; Cowen DM; Levegrün S; Burman CM; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):103-13. PubMed ID: 10758311
[TBL] [Abstract][Full Text] [Related]
19. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
[TBL] [Abstract][Full Text] [Related]
20. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions.
Fiorino C; Cozzarini C; Vavassori V; Sanguineti G; Bianchi C; Cattaneo GM; Foppiano F; Magli A; Piazzolla A
Radiother Oncol; 2002 Jul; 64(1):1-12. PubMed ID: 12208568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
